These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34815670)

  • 1. The Advances of Neutrophil-Derived Effective Drug Delivery Systems: A Key Review of Managing Tumors and Inflammation.
    Wang H; Zang J; Zhao Z; Zhang Q; Chen S
    Int J Nanomedicine; 2021; 16():7663-7681. PubMed ID: 34815670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-Based Drug Delivery Systems.
    Chu D; Dong X; Shi X; Zhang C; Wang Z
    Adv Mater; 2018 May; 30(22):e1706245. PubMed ID: 29577477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospects and challenges of exosomes as drug delivery systems].
    Meng W; Li L; Zhu G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Aug; 37(4):714-720. PubMed ID: 32840090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-Based Delivery Systems for Nanotherapeutics.
    Han Y; Zhao R; Xu F
    Small; 2018 Oct; 14(42):e1801674. PubMed ID: 30144279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic approaches for targeting tumor-promoting inflammation.
    Parodi A; Kostyushev D; Brezgin S; Kostyusheva A; Borodina T; Akasov R; Frolova A; Chulanov V; Zamyatnin AA
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):555-567. PubMed ID: 35472397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment.
    Zhang Y; Guoqiang L; Sun M; Lu X
    Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection.
    Chu D; Gao J; Wang Z
    ACS Nano; 2015 Dec; 9(12):11800-11. PubMed ID: 26516654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-mediated delivery of nanotherapeutics across blood vessel barrier.
    Dong X; Chu D; Wang Z
    Ther Deliv; 2018 Jan; 9(1):29-35. PubMed ID: 29216803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes as drug carriers for clinical application.
    Di C; Zhang Q; Wang Y; Wang F; Chen Y; Gan L; Zhou R; Sun C; Li H; Zhang X; Yang H; Zhang H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S564-S570. PubMed ID: 30431368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy.
    Wang J; Tang W; Yang M; Yin Y; Li H; Hu F; Tang L; Ma X; Zhang Y; Wang Y
    Biomaterials; 2021 Jun; 273():120784. PubMed ID: 33848731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Glycan Derived Biomaterials for Inflammation Targeted Drug Delivery.
    Niu Y; Xue Q; Fu Y
    Macromol Biosci; 2021 Sep; 21(9):e2100162. PubMed ID: 34145960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil membranes coated, antibiotic agent loaded nanoparticles targeting to the lung inflammation.
    Wang K; Lei Y; Xia D; Xu P; Zhu T; Jiang Z; Ma Y
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110755. PubMed ID: 31887646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophils as an emerging therapeutic target and tool for cancer therapy.
    Subhan MA; Torchilin VP
    Life Sci; 2021 Nov; 285():119952. PubMed ID: 34520766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome: a significant nano-scale drug delivery carrier.
    Peng H; Ji W; Zhao R; Yang J; Lu Z; Li Y; Zhang X
    J Mater Chem B; 2020 Sep; 8(34):7591-7608. PubMed ID: 32697267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using exosomes, naturally-equipped nanocarriers, for drug delivery.
    Batrakova EV; Kim MS
    J Control Release; 2015 Dec; 219():396-405. PubMed ID: 26241750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration.
    Zhang X; Shi H; Yuan X; Jiang P; Qian H; Xu W
    Mol Cancer; 2018 Oct; 17(1):146. PubMed ID: 30292233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-targeted, protease-activated pulmonary drug delivery blocks airway and systemic inflammation.
    Mejías JC; Forrest OA; Margaroli C; Frey Rubio DA; Viera L; Li J; Xu X; Gaggar A; Tirouvanziam R; Roy K
    JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31661469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate.
    Shao J; Zaro J; Shen Y
    Int J Nanomedicine; 2020; 15():9355-9371. PubMed ID: 33262592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil Membrane-Derived Nanovesicles Alleviate Inflammation To Protect Mouse Brain Injury from Ischemic Stroke.
    Dong X; Gao J; Zhang CY; Hayworth C; Frank M; Wang Z
    ACS Nano; 2019 Feb; 13(2):1272-1283. PubMed ID: 30673266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.